Abvc Biopharma (ABVC) Payables (2009 - 2026)
Abvc Biopharma (ABVC) recorded Payables of $4.56 million in Q3 2026, down 4.9% from $4.8 million a year earlier but up 7.1% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Payables (2009 - 2026) Analysis & Trends
At the end of FY2025, Abvc Biopharma reported Payables of $4.92 million, up 13.0% from FY2024.
- Annual Payables has a five-year compound annual growth rate of 24.4% (FY2020 to FY2025).
- Across earlier years, Payables came in at $4.35 million in FY2024 (-2.2%), $4.45 million in FY2023 (+134.9%), $1.89 million in FY2022 (+15.5%) and $1.64 million in FY2021 (-0.7%).
- Quarterly Payables has ranged from $852,500 in Q3 2023 to $5.16 million in Q2 2025 over the past five years.
- On a year-over-year basis, Payables has declined for three consecutive quarters, with growth averaging 0.9% over the last eight quarters.
- Peak year-over-year performance for Payables in the last five years was growth of 426.3% in Q3 2024, against a decline of 54.3% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.26 million (Q2 2026), $4.24 million (Q1 2026) and $4.92 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 5.79 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 18.17 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 34.43 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 7.17 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -25.19 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.95 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 934.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.07 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 4.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.56 Mn |
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 4.24 Mn |
| Dec 31, 2025 | 4.92 Mn |
| Sep 30, 2025 | 4.80 Mn |
| Jun 30, 2025 | 5.16 Mn |
| Mar 31, 2025 | 4.63 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 4.49 Mn |
| Jun 30, 2024 | 4.59 Mn |
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 4.45 Mn |
| Sep 30, 2023 | 852,500.00 |
| Jun 30, 2023 | 882,750.00 |
| Mar 31, 2023 | 902,000.00 |
| Dec 31, 2022 | 1.89 Mn |
| Sep 30, 2022 | 1.87 Mn |
| Jun 30, 2022 | 1.58 Mn |
| Mar 31, 2022 | 1.61 Mn |
| Dec 31, 2021 | 1.64 Mn |
API Access
Abvc Biopharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();